Ribociclib Improves Survival in Post-Menopausal Women With Metastatic Breast Cancer
246,660 women will be diagnosed with breast cancer in 2016, and 40,450 women will die from the...
WHAT'S UP IN
Progression-free survival
Ribociclib improves progression-free survival in advanced breast cancer
The addition of the CDK4/6 inhibitor ribociclib to letrozole therapy significantly improves...
ESMO 2016: Ribociclib Improves Progression-Free Survival in Advanced Breast Cancer
The addition of the CDK4/6 inhibitor ribociclib to letrozole therapy significantly improved...
MD Anderson-led study finds ribociclib improves progression-free survival for women with metastatic breast cancer
IMAGE: This is Gabriel Hortobagyi, M.D. view more Copenhagen, Denmark – In a randomized,...
Study finds ribociclib improves progression-free survival for women with metastatic breast cancer
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer...
